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Objectives: In this study we sought to compare the clinical outcomes of micropuncture femoral to radial artery access in patients undergoing 
percutaneous coronary interventions.
Background: Despite a recent emergence of data to support superiority of radial artery access, the femoral artery is still the most common access 
site used for percutaneous coronary interventions. Bleeding complications and transfusions are a cause of worse outcomes in these patients. Recent 
data has shown reduced bleeding complications with a micropuncture needle compared to large bore needle (18 G) for femoral artery access.
Methods: 573 patients at a high volume university medical center were divided into two different groups of arterial access, femoral-fluoroscopy 
with micropuncture needle (5Fr) versus radial access. Cardiology fellows obtained access in greater than 90% of all patients.
Results: Transfusion rates (GUSTO moderate bleeding) with femoral access using a micropuncture needle are significantly higher compared to 
radial access in percutaneous coronary interventions. Fluoroscopy time is significantly higher in the radial access compared to micropuncture 
femoral arterial access group. 
Micropuncture Femoral Radial p-value
Total PCI Patients (N = 573) 357 216
BMI (mean) 30.7±7.0 31.6±7.1 0.079
STEMI 9(2.5%) 14(6.4%)
Mean Door-to-Balloon Time 41.4±18.6 52.6±14.8 0.075
Bivalirudin Usage 97(27%) 4(1.9%) <0.001
Outcomes
In-Hospital Mortality 3(0.8%) 4(1.8%) 0.16
Any Vascular Complication 4(1.1%) 1(0.05%) 0.051
Bleeding Event Within 72 hours 11(3.0%) 0(0.0%) <0.001
RBC/Whole Blood Transfusion (GUSTO moderate) 12(3.3%) 1(0.05%) 0.003
Fluoroscopy Time (mean min.) 14.5±8.8 20.0±12.7 <0.001
Conclusions: In this single center trial, using micropuncture needle for femoral arterial access has not reduced GUSTO moderate bleeding when 
compared to radial access in percutaneous coronary interventions.
